1. Home
  2. RANI vs CURV Comparison

RANI vs CURV Comparison

Compare RANI & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

N/A

Current Price

$1.12

Market Cap

126.8M

Sector

Health Care

ML Signal

N/A

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

HOLD

Current Price

$1.75

Market Cap

124.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
CURV
Founded
2012
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
126.8M
124.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RANI
CURV
Price
$1.12
$1.75
Analyst Decision
Strong Buy
Hold
Analyst Count
4
6
Target Price
$8.50
$1.59
AVG Volume (30 Days)
925.4K
1.4M
Earning Date
05-12-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
21.05
36.36
EPS
N/A
0.01
Revenue
$1,028,000.00
$1,103,737,000.00
Revenue This Year
$414.59
N/A
Revenue Next Year
$30.15
$0.21
P/E Ratio
N/A
$178.00
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.94
52 Week High
$3.87
$6.69

Technical Indicators

Market Signals
Indicator
RANI
CURV
Relative Strength Index (RSI) 35.82 79.56
Support Level $1.07 $1.63
Resistance Level $1.54 $1.96
Average True Range (ATR) 0.07 0.14
MACD -0.03 0.06
Stochastic Oscillator 15.71 80.89

Price Performance

Historical Comparison
RANI
CURV

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.

Share on Social Networks: